Cyanotech Corp

CYAN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $32.0M $31.8M $33.8M $28.2M $27.5M $24.6M $16.8M $15.7M
Cost of Revenue $19.8M $20.0M $19.3M $17.0M $16.6M $14.9M $10.5M $9.1M
Gross Profit $12.2M $11.9M $14.5M $11.2M $10.9M $9.8M $6.3M $6.6M
Gross Margin 38.1% 37.3% 42.8% 39.7% 39.6% 39.7% 37.7% 42.1%
Operating Expenses
Research & Development $593.0K $633.0K $517.0K $469.0K $258.0K $320.0K $282.0K $264.0K
SG&A Expense $6.1M $5.8M $8.0M $6.4M $4.7M $4.0M $2.8M $3.3M
Operating Income $-682.0K $-785.0K $322.0K $-210.0K $2.2M $2.9M $1.2M $1.5M
Operating Margin -2.1% -2.5% 1.0% -0.7% 8.1% 11.8% 7.3% 9.5%
Interest Expense
Pretax Income $-1.2M $-1.1M $229.0K $-328.0K $2.1M $2.9M $1.2M $1.4M
Income Tax Expense $5.0K $3.3M $253.0K $92.0K $-2.1M $-779.0K $-567.0K $24.0K
Net Income $-1.2M $-4.4M $-24.0K $-420.0K $4.2M $3.6M $1.7M $1.4M
Net Margin -3.8% -13.8% -0.1% -1.5% 15.2% 14.7% 10.3% 8.8%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 6.13B 6.04B 5.97B 5.93B 5.91B 5.86B 5.80B 5.69B
Shares Outstanding (Diluted) 6.13B 6.04B 5.97B 5.93B 6.12B 5.99B 5.86B 5.79B
Dividends Per Share
← Newer Page 2 of 2 Older →